# Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

> **NCT04295447** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Universität Münster** · enrollment: 190 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **OTHER:** Standard of care
- **DRUG:** Apalutamide 60Mg Tab

## Key facts

- **NCT ID:** NCT04295447
- **Lead sponsor:** Universität Münster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-10
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295447, "Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04295447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*